Changes in CYP2D enzyme activity following induction of type 2 diabetes, and administration of cinnamon and metformin: an experimental animal study

References

• Allen RW, Schwartzman E, Baker WL, et al. (2013). Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11:452–9.
   PubMed Web of Science ®Google Scholar
• Association AD. (2017). Standards of medical care in diabetes—2017: summary of revisions. Diabetes Care 40:S4–5.
   PubMed Web of Science ®Google Scholar
• Babu PS, Prabuseenivasan S, Ignacimuthu S. (2007). Cinnamaldehyde—a potential antidiabetic agent. Phytomedicine 14:15–22.
   PubMed Web of Science ®Google Scholar
• Detoma AS, Salamekh S, Ramamoorthy A, Lim MH. (2012). Misfolded proteins in Alzheimer's disease and type II diabetes. Chem Soc Rev 41:608–21.
   PubMed Web of Science ®Google Scholar
• Dostalek M, Akhlaghi F, Puzanovova M. (2012). Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs. Clin Pharm 51:481–99.
   Google Scholar
• Ekor M. (2013). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177.
   Web of Science ®Google Scholar
• Giacco F, Brownlee M. (2010). Oxidative stress and diabetic complications. Circ Res 107:1058–70.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2006). Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8:E101–11.
   PubMed Web of Science ®Google Scholar
• Harati Y, Gooch C, Swenson M, et al. (2000). Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complicat 14:65–70.
   PubMed Web of Science ®Google Scholar
• Hou X, Song J, Li X-N, et al. (2010). Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 396:199–205.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. (2005). Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom J 5:6–13.
   PubMed Web of Science ®Google Scholar
• Katon WJ. (2008). The comorbidity of diabetes mellitus and depression. Am J Med 121:S8–S15.
   PubMed Web of Science ®Google Scholar
• Kudo T, Shimada T, Toda T, et al. (2009). Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity. Xenobiotica 39:889–902.
   PubMed Web of Science ®Google Scholar
• Lavasani H, Sheikholeslami B, Ardakani YH, et al. (2013). Study of the pharmacokinetic changes of Tramadol in diabetic rats. DARU J Pharm Sci 21:17.
   Web of Science ®Google Scholar
• Leach MJ, Kumar S. (2012). Cinnamon for diabetes mellitus. Cochrane Database Syst Rev 9:CD007170.
   Google Scholar
• Lewis DF. (2004). 57 varieties: the human cytochromes P450. Pharmacogenomics 5:305–18.
   PubMed Web of Science ®Google Scholar
• Long AN, Dagogo‐Jack S. (2011). Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens 13:244–51.
   PubMed Web of Science ®Google Scholar
• Maddox PJ. (2016). Cinnamon in the treatment of type II diabetes.
   Google Scholar
• Graduate Research Projects 79. Available from: http://knowledge.e.southern.edu/gradnursing/79 [last accessed 18 Oct 2017]
   Google Scholar
• Matzke GR, Frye RF, Early JJ, et al. (2000). Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity. Pharmacotherapy 20:182–90.
   PubMed Web of Science ®Google Scholar
• Murray M. (2006). Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metabol 7:67–81.
   PubMed Web of Science ®Google Scholar
• Pedersen RS, Damkier P, Brosen K. (2005). Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study. Clin Pharmacol Ther 77:458–67.
   PubMed Web of Science ®Google Scholar
• Qin B, Panickar KS, Anderson RA. (2010). Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol 4:685–93.
   PubMedGoogle Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. (2008). Dose translation from animal to human studies revisited. FASEB J 22:659–61.
   PubMed Web of Science ®Google Scholar
• Shimojo N, Ishizaki T, Imaoka S, et al. (1993). Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem Pharmacol 46:621–7.
   PubMed Web of Science ®Google Scholar
• Smith HS. (2009). Opioid metabolism. Mayo Clin Proc 84:613–24.
   PubMed Web of Science ®Google Scholar
• Sotaniemi EA, Pelkonen O, Arranto AJ, et al. (2002). Diabetes and elimination of antipyrine in man: an analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement. Pharmacol Toxicol 90:155–60.
   PubMedGoogle Scholar
• Vgontzas AN, Liao D, Pejovic S, et al. (2009). Insomnia with objective short sleep duration is associated with type 2 diabetes. Diabetes Care 32:1980–5.
   PubMed Web of Science ®Google Scholar
• Villeneuve J-P, Pichette V. (2004). Cytochrome P450 and liver diseases. Curr Drug Metabol 5:273–82.
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Garcia NS, et al. (2012). Cellular and molecular mechanisms of metformin: an overview. Clin Sci 122:253–70.
   PubMed Web of Science ®Google Scholar
• Vitale C, Mercuro G, Cornoldi A, et al. (2005). Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med 258:250–6.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2016). Global report on diabetes. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–41.
   PubMed Web of Science ®Google Scholar
• Zuber R, Anzenbacherova E, Anzenbacher P. (2002). Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med 6:189–98.
   PubMed Web of Science ®Google Scholar